Bioartificial Heart
Organ Failure / Transplantation
Pre-clinicalActive
Key Facts
About TissueLabs
TissueLabs is a private, Zurich-based company developing and commercializing a comprehensive biofabrication platform centered on 3D bioprinting systems and specialized biomaterials. Originating from an ambitious internal project to create a bioartificial heart, the company pivoted to democratize its enabling technologies for the global research community. It operates as a platform tools company, selling hardware, consumables, and kits to accelerate R&D in biomedical science, positioning itself in the early-revenue stage of the growing tissue engineering market.
View full company profileTherapeutic Areas
Other Organ Failure / Transplantation Drugs
| Drug | Company | Phase |
|---|---|---|
| Bioengineered Tissue Program | iOrganBio | Pre-clinical |